Current Enzyme Inhibition
Aims and Scope:
Current Enzyme Inhibition aims to publish original research, full-length/mini review and letter articles in all the latest and outstanding developments on enzyme inhibition studies. The coverage includes the mechanisms of inhibitory processes of enzymes, recognition of active sites, and the discovery of agonists and antagonists, leading to the design and development of new drugs of significant therapeutic value.
Current Enzyme Inhibition is an essential journal for every pharmaceutical researcher and medicinal chemist who wishes to have up-to-date knowledge about each and every development in the study of enzyme inhibition.
Editor-in-Chief:
-
Claudiu T. Supuran Department of Neurofarba
University of Florence
Florence
Italy
ISSN: 1573-4080 (Print)
eISSN: 1875-6662 (Online)
Special Issues With Active Call for Papers
Recent Advances in Enzyme Inhibition Strategies for the Treatment and Management of Colorectal Cancer
Colorectal cancer (CRC) is among the leading causes of cancer-related morbidity and mortality worldwide, with therapeutic resistance and metastatic progression remaining major challenges. Enzyme inhibition has emerged as a promising strategy for CRC prevention and treatment, targeting key molecular pathways involved in tumor growth, invasion, and chemoresistance. This thematic issue will highlight recent advances in the discovery, design, and application of enzyme inhibitors in CRC, including kinase inhibitors, histone deacetylase and other epigenetic modulators, matrix... see more